United States· US:10702-223_116f0b5b-cbad-8216-e063-6294a90a9a13
Atovaquone Oral Suspension
A atovaquone product containing atovaquone, registered in United States by KVK-Tech, Inc.. The same ATC class is registered in 11 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Atovaquone is registered in 11 of 19 countries.
Countries holding a registration under ATC P01AX06 (atovaquone), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 5 of them publish a price we can compare per daily dose
Atovaquone · ATC P01AX06
11 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Franceprice
- Germany
- Netherlands
- Norwayprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Atovaquone
- Manufacturer
- KVK-Tech, Inc.
- Country
- United States (US)
- ATC code
- P01AX06
- ATC class
- Atovaquone
- Defined daily dose
- 1.5 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 1
- ndc1110702223211 BOTTLE, PLASTIC in 1 CARTON (10702-223-21) / 210 mL in 1 BOTTLE, PLASTIC
Regulatory notes
Interactions
182 interactions on record for atovaquone.
Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Atovaquone · interactions on record
182 records
- 8 severe
- 32 moderate
- 4 minor
- 133 info
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- EfavirenzJ05AG03severe
- PexidartinibL01EX15severe
5 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Atovaquone in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenAtovaquone Glenmark 150 mg/ml Oral suspensionGlenmark Arzneimittel GmbH
- FranceATOVAQUONE BIOGARAN 750 mg/5mL, suspension buvableBIOGARAN
- NetherlandsAtovaquon Glenmark 750 mg/5 ml suspensie voor oraal gebruikGlenmark Arzneimittel GmbH
- BelgiumWellvone 750 mg/5 mlGlaxoSmithKline Pharmaceuticals
- NorwayWellvone SuspensionGlaxoSmithKline
- United KingdomAtovaquone 750mg/5ml oral suspension sugar freeA A H Pharmaceuticals Ltd
- CanadaGLN-ATOVAQUONEGLENMARK PHARMACEUTICALS CANADA INC.
- GermanyAtovaquon GlenmarkGlenmark Arzneimittel Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Belgium · Wellvone
- Germany · Atovaquon Glenmark, Wellvone
- Denmark · Atovaquone Glenmark
- Spain · Atovacuona Glenmark, Wellvone
- France · Atovaquone Biogaran, Wellvone
- United Kingdom (Northern Ireland) · Atovaquone Amarox, Atovaquone Glenmark Pharmaceuticals Europe
- Greece · Atovaquone Vocate, Wellvone
- Italy · Atovaquone Glenmark, Wellvone
- Luxembourg · Wellvone
- Netherlands · Atovaquon Glenmark, Wellvone
- Norway · Atovaquone Glenmark
- Portugal · Atovaquona Kabi, Wellvone
- Sweden · Atovaquone Glenmark, Wellvone
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bf41e6f1-2b4c-41b7-8c7d-294b6e7e5945 GET /v1/drugs/bf41e6f1-2b4c-41b7-8c7d-294b6e7e5945?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "Y883P1Z2LT",
"rxcui": "60212",
"inchikey": "KUCQYCKVKVOKAY-CTYIDZIISA-N",
"display_name": "ATOVAQUONE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 4
},
"spl_meta": {
"ad25ab65-42aa-48f6-b5ed-247f3685d5bf": {
"match": "brand_token",
"title": "ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLET, FILM COATED [BLUEPOINT LABORATORIES]",
"spl_version": "8",
"published_date": "2026-05-29"
}
},
"productid": "10702-223_116f0b5b-cbad-8216-e063-6294a90a9a13",
"productndc": "10702-223",
"dosage_form": "SUSPENSION",
"orange_book": {
"appl_no": "210510",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "750MG/5ML",
"product_no": "001",
"approval_date": "May 31, 2019"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "ATOVAQUONE",
"proprietary_name": "Atovaquone Oral Suspension",
"active_ingred_unit": "mg/5mL",
"application_number": "ANDA210510",
"marketing_category": "ANDA",
"nonproprietary_name": "Atovaquone",
"start_marketing_date": "20190329",
"active_numerator_strength": "750"
}See everything about atovaquone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.